Finanzwire Finanzwire
Basculer en Français
9629 Companies
191463 Keywords
122919 Articles
102033 Press releases
Headlines Articles Press releases Vascular Therapies Remove
  1. Home
  2. Companies
  3. Vascular Therapies
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 08/05/2024 at 16:05, 1 year 5 months ago

    Vascular Therapies Completes Enrollment in Phase III ACCESS 2 Study for Sirogen

    Clinical Trial Vascular Access Sirolimus AV Fistula Hemodialysis
  • PRESS RELEASE

    published on 08/05/2024 at 16:00, 1 year 5 months ago

    Vascular Therapies Completes Enrollment in the ACCESS 2 Study, a Phase III Multinational Randomized Clinical Trial of the Sirolimus Eluting Collagen Implant (Sirogen) for the Surgical Creation of Arteriovenous Fistula for Hemodialysis Vascular Access

    Vascular Therapies completes enrollment in Phase III ACCESS 2 trial to evaluate perivascular sirolimus for AV fistula in kidney disease patients. Topline results expected Q2 2025
    Kidney Disease AV Fistula Vascular Therapies Perivascular Sirolimus ACCESS 2 Trial
    Logo of Vascular Therapies
Accesswire
  • Published on 01/10/2026 at 05:10, 1 day 21 hours ago

    Sekur Private Data Ltd. Announces Non-Brokered Private Placement

  • Published on 01/10/2026 at 00:45, 2 days 1 hour ago

    Digi Power X Announces Entry into Settlement Agreement

  • Published on 01/09/2026 at 23:30, 2 days 3 hours ago

    Sun Peak Metals Grants Stock Options

  • Published on 01/09/2026 at 23:30, 2 days 3 hours ago

    Matador Technologies Announces Grant of Restricted Share Units to Management Team

  • Published on 01/09/2026 at 23:10, 2 days 3 hours ago

    Usha Resources and Totec Resources Provide Supplemental Disclosure for Qualifying Transaction

View all ACCESSWIRE
EQS Group
  • Published on 01/12/2026 at 00:10, 2 hours 29 minutes ago

    EQS-Adhoc: Northern Data Announces Expiry of Option to Sell Corpus Christi Site to Global Infrastructure Asset Management Firm

  • Published on 01/11/2026 at 22:20, 4 hours 19 minutes ago

    Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

  • Published on 01/10/2026 at 21:25, 1 day 5 hours ago

    CATL Opens Middle East's Largest New Energy Aftermarket Facility in Riyadh

  • Published on 01/10/2026 at 13:05, 1 day 13 hours ago

    SeaVerse Launches World's First AI Native Platform, "All in AI Native" Leads the Forward-Looking Revolution in AI Creation

  • Published on 01/09/2026 at 21:55, 2 days 4 hours ago

    Piramal Pharma Achieves Notable Score Increase on 2025 S&P Global Corporate Sustainability Assessment (CSA)

View all EQS
Les Echos
  • Published on 01/09/2026 at 18:30, 2 days 8 hours ago

    H2 2025 half yearly report on the liquidity agreement signed with the Gilbert Dupont brokerage firm

  • Published on 01/09/2026 at 17:45, 2 days 8 hours ago

    January 2026

  • Published on 01/09/2026 at 17:45, 2 days 8 hours ago

    MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

  • Published on 01/09/2026 at 17:42, 2 days 8 hours ago

    Aéroports de Paris SA - Shares and voting rights as of 31 December 2025

  • Published on 01/08/2026 at 21:00, 3 days 5 hours ago

    Biannual report on SEB S.A.’S liquidity agreement

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy